Dysregulation of the IL-6/IL-6R system has been associated with the pathogenesis of several autoimmune and inflammatory diseases in humans, and anti-IL-6 monoclonal antibodies (moAbs) have been successfully developed for the medical treatment of chronic inflammatory diseases, like rheumatoid arthritis [3]. This evidence concerns the gene IL6 and rheumatoid arthritis.